The AI in Genomics Market was valued at USD 235.64 million in 2022 and is projected to reach USD 4759.27 million by 2030. The market is anticipated to expand with a stellar CAGR of 45.6% over the forecast period. Artificial intelligence can speed up and reduce the risk of pharmaceutical production, making it easier for physicians to study intricate illnesses at the genetic level. The AI in the genomics market is predicted to rise further due to the advent of novel and effective solutions for illness diagnosis and monitoring.
INDUSTRY OVERVIEW
Genomics is a field of science that studies genes and their functions, as well as the structure, evolution, and mapping of genomes in living creatures. The genetic test is used to learn about illness susceptibility, drug response, and human biology in general. Analysis of structure and function, DNA sequencing, bioinformatics for sequencing, and recombinant DNA are all part of genomics research. In genomics, artificial intelligence (AI) is used to construct computer systems that can execute tasks like genome mapping. Furthermore, AI aids in the quicker study of the structure, evolution, and function of genetic material than human interaction allows. AI algorithms are utilised in clinical genomics to undertake genomic analysis such as genome annotation, variant calling, and phenotype-to-genotype correlation. Additionally, AI approaches can aid in the accurate prediction of protein structure or DNA data with minimum feature handcrafting.
Precision medicine and drug discovery departments of the healthcare and pharmaceutical industries employ services from the worldwide artificial intelligence in the genomics industry. These solutions make use of a range of technologies, including computer vision and machine learning. They can also be employed in the healthcare business for diagnostic purposes. The services and software provided by participants in the worldwide artificial intelligence in the genomics market are used to automate or intelligently manage arduous and time-consuming procedures in the drug development process.
The necessity to keep pharmaceutical research and development costs and timelines under control is propelling artificial intelligence in the genomics industry forward. The Global Artificial Intelligence in Genomics Market is expected to grow during the projected period as the demand to limit discovery costs and time during new medication development grows. Drug development is a time-consuming, complicated, and costly process that necessitates the application of several technologies in the quest for innovative medicines. However, a scarcity of experienced workers with expertise in AI technologies, as well as ambiguous and strict rules and norms governing the creation and deployment of medical software tools and platforms, may limit the worldwide artificial intelligence in genomics market growth in the next years.
The outbreak of COVID-19 had a favourable influence on the healthcare industry growth. In the foreseeable future, technological advancements, the need for controlling costs, and improved accessibility to medical systems are expected to be key parts of healthcare reforms. Amid the continuing pandemic, digital health and telemedicine have come to the forefront. The relevance of remote diagnosis, care, and consultation was re-emphasized during COVID-19. Regulatory and behavioural constraints have hindered telehealth's growth in recent years. The category is expected to increase over the next two years since many healthcare providers are actively focusing on video conferencing and telephone conversations. Furthermore, individuals with mild symptoms were required to consult online as part of the social distancing procedures. Furthermore, it alleviated the strain on hospitals that were already overburdened with COVID-19 patient counts. At-home medical IoT devices are currently being utilised to optimise outpatient therapy and reduce recurrent visits, and they may even be employed in a crisis. The epidemic put a strain on available resources. This is projected to lead to the development of competitive pricing and value-based pricing structures, boosting the AI in the genomics market.
MARKET DRIVERS:
The burgeoning Need to Reduce the Cost and Time of Drug Development is acting as a market driver for the AI in Genomics market
In drug discovery and development, in vivo and in vitro techniques, which are both costly and time-consuming, are widely employed. Artificial intelligence is playing an increasingly important role in drug discovery, with the potential to save a significant amount of time and money. As a result, AI in genomics is gaining traction as a viable option for drug discovery; it examines large datasets to find novel therapies in less time than traditional approaches which are eventually fueling the market expansion.
Increasing incidences of diseases such as cancer, diabetes and the rising adoption of AI solutions in precision medicine are propelling the market growth
Genome testing increases public awareness of genetic disorders and can give individualised information on health, disease risk, and other factors. New technology developments and the increased frequency of several genetic illnesses such as diabetes, cancer, cystic fibrosis, and Alzheimer's disease are driving worldwide growth. Real-time drug discovery, cutting-edge diagnostic technologies, and enhanced therapies are projected to drive business expansion. Consumers may be able to adopt a more proactive approach to their health as a result of this technology. DNA samples are routinely collected in an easy and non-invasive manner, and the results are usually available quickly. Other factors driving market expansion include increased user awareness, disposable income, and healthcare spending, as well as rising acceptance of tailored medicine to treat genetic illnesses.
MARKET RESTRAINTS:
Stringent rules and regulations by authorities in the development and deployment of medical software tools and platforms may hamper the growth of artificial intelligence in the genomics market
The slow approval rate by the concerned authorities and strict rules and regulation regarding the development and deployment of medical software tools and platforms across the world is acting as a major hindrance to market growth. The genomics market is a very specialized field. The product has to undergo certain standardization and quality test. The authorities follow strict regulations and parameters in approving any product or drugs. The quality check and standardization process sometimes take a longer duration which affects the overall market growth.
The lack of a skilled workforce in the genomics market is projected to hamper the market growth
As the AI in the genomic industry grows, it may face major hiring problems, especially for developing industry segments like regenerative medicine. Overall, the steady growth of the genomics market will be negatively affected by a lack of skilled workers. The need for trained staff, and expertise has remained the basic requirement over years. That problem is likely to worsen and act as a major restraint to the market growth.
AI in Genomics Market Report Coverage:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2023 - 2030 |
|
Base Year |
2022 |
|
Forecast Period |
2023 - 2030 |
|
CAGR |
45.6% |
|
Segments Covered |
By Offering, Technology, Application, End-User and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Key Companies Profiled |
DNAnexus Inc., Lifebit, Empiric Logic, Microsoft, MolecularMatch Inc., Sophia GENETICS, Cambridge Cancer Genomics, Data4Cure Inc., Genoox Ltd., Diploid, Engine Biosciences Pte. Ltd., IBM, NVIDIA Corporation, Benevolent AI, Verge Genomics |
This research report on AI in Genomics Market has been segmented and sub-segmented based on Offering, By Technology, By Application, By End - User and By Region.
Based on offering, the AI in the genomics market is segmented into Software, Services and Consumables. Among these, the consumables segment captured the majority of the market share in 2021. Owing to the factor that consumables are widely utilised in genomic systems, their use will continue to expand as the number of genetic tests done throughout the world increases and is the key reason driving the segment growth. The software segment is also projected to expand exponentially over the forecast period. This market growth can be attributed to the reason that AI may be deployed as software that can replicate and even surpass human intellect in some situations. As the complexity of genetic data grows, researchers are turning to artificial intelligence and machine learning to uncover important correlations which are eventually driving the use of AI in the genomics market.
Based on Technology, the AI in the genomics market is segmented into Machine learning and Computer Vision. Among these, the Machine learning segment dominated the worldwide AI in genomics market in 2021. The machine learning segment is anticipated to expand at a higher CAGR during the forecast period. The market dominance of this segment is due to the reason that genomics generates large amounts of data, most bioinformatics algorithms employ machine learning approaches to discover patterns and forecast outcomes. Furthermore, pharmaceutical and biotechnology businesses are increasingly using machine learning for drug-genomic applications since it retrieves useful information from large data sets and complements genomic research which is consequently influencing the market towards a positive trend.
Based on application, the AI in the genomics market is divided into Genome Sequencing, Gene Editing and Gene Mapping. Among these, the genome sequencing category held the greatest proportion of the genomics market in 2021. The benefits of sequencing technologies, such as ultra-high throughput, scalability, and speed, allow researchers to execute a wide range of tasks, including animal breeding, agriculture, and human genomics acting as one of the segment's main driving forces. Gene editing is also poised to capture a significant market share shortly. Conventional operations and medications are projected to be replaced by advances in gene therapy. This will allow doctors to treat a disease by putting a gene into their patients' cells. Gene editing is a delicate and powerful breakthrough in the genomics market. It has been a source of debate, discussion, and, despite flaws, excitement and innovation for a long time.
Based on end-user, the AI in the genomics market is divided into pharmaceutical companies and research bodies. Among these, the pharmaceutical company segment contributed the maximum to the market share. The market growth is primarily driven by the fact that Artificial intelligence can expedite the development process and also aids in reducing the risk of pharmaceutical production, making it easier for physicians to study intricate illnesses at the genetic level. The AI in the genomics market is predicted to rise further due to the advent of novel and effective solutions for illness diagnosis and monitoring. Data is an important aspect of medication research for pharmaceutical firms since it provides proof of safety and efficacy. As a result, AI assists in the efficient and secure analysis of this data. The increased frequency of illnesses such as cancer and genetic disorders, as well as the growing need to cut medication development time and costs, are anticipated to promote this segment growth.
By region, the AI in the genomics market is grouped into North America, Europe, Asia Pacific and the rest of the world. North America emerged as the largest regional market in AI in the genomics market in 2021 and contributed the largest to the market share of 45.19% and is anticipated to continue with the trend during the forecast period. This anticipated trend might be linked to increased financing as well as government measures targeted at increasing industrial research. Furthermore, government efforts and expenditures intended at boosting precision medical practices in the United States are likely to aid the market's growth trajectory in North America throughout the forecast period. In addition, technical advancements have lowered the cost of sequencing on the market. This has piqued patients' interest in personal genome sequencing for future individualised medicines, lifestyle, dietary studies, and other genomics research. North America is one of the world's top AI marketplaces, and it is paving the way for other nations to apply AI in genomics and diagnostics in the medical profession. Because of the increased usage of AI in genome sequencing and raising awareness among local pharma and biotech organisations, the AI in the genomics market is predicted to develop in North America.
Due to increased awareness of genetics and the availability of financing for long-term research programmes, the market for consumer genomics in the Asia Pacific has significant development potential and is anticipated to expand at a higher CAGR in the coming years. The expansion of the regional market is also boosted by the entrance of new market participants.
AI IN GENOMICS MARKET- BY COMPANIES
Some of the major players operating in the AI in genomics market include
NOTABLE HAPPENING IN AI IN THE GENOMICS MARKET
FUNDING- In March 2022, To develop a genetic data analytics platform, DNAnexus received $200 million in investment from Perceptive Advisors, Innovatus Capital Partners, Foresite Capital, and Northpond Ventures, and Alphabet's venture arm GV.
COLLABORATION- In October 2021, Eurofins Genomics and Poolbeg Pharma collaborated to complete next-generation RNA sequencing of RSV (respiratory syncytial virus) illness progression samples from human viral challenge experiments.
COLLABORATION- In July 2021, Verge Genomics and Eli Lily entered into a collaboration for three years. The purpose of this collaboration is to conduct research and development for novel medications to treat amyotrophic lateral sclerosis (ALS), a motor neuron disease. Eli Lily would leverage Verge's all-in-human platform to uncover and create novel ALS targets as part of this collaboration.
COLLABORATION- In October of 2020, NVIDIA Corporation announced a collaboration with GSK, a prominent participant in the global healthcare market. This cooperation was formed with GSK's AI department, and it was utilised to assist their team in the United Kingdom in improving their vaccination and drug discovery processes by utilising the NVIDIA platform.
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
